www.tri-conference.com/speaker_bios/cristopher_ko.asp -
[Cached Version]
Published on: 10/6/2008
Last Visited: 5/11/2008
Dr. Ko is currently Vice President at Samsung Advanced Institute of Technology, the central R&D organization of Samsung Electronics, Ltd., and he is Director of Bio & Health Research Laboratory.Dr. Ko was previously Vice President of Corporate Development at Dyax Corp (DYAX; NASDAQ), a company that makes peptide and antibody therapeutics via phage display.Previously, Dr. Ko served as Chief Executive Officer of Target Quest, a human antibody therapeutics company that subsequently merged with the then privately held Dyax Corp.Prior to starting Target Quest, Dr. Ko served as Associate Director of Corporate Development at Hyseq, Inc. (NUVO; NASDAQ) He holds a B.A. from University of California, Berkeley and a Ph.D. from Northwestern University, and did his postdoctoral work at
6 online sources [ view sources ]
Profile is not claimed [ this is me ]
